TY  - JOUR

T1  - P106 A Number-Needed-to-Treat(NNT) analysis of bonerelapse and mortality in a randomized trial of oral clodronate as supplementary adjuvant therapy for operable breast cancer

JO  - The Breast

UR  - https://doi.org/10.1016/s0960-9776(05)80142-0

PY  - 2005/02/01

AU  - Powles T

AU  - Paterson A

AU  - McCloskey E

AU  - Kanis J

ED  - 

DO  - DOI: 10.1016/s0960-9776(05)80142-0

PB  - Elsevier BV

VL  - 14

SP  - S45

EP  - S45

Y2  - 2026/11/03

ER  -